A Michaud1,2,3, J Tordjman4,5, M Pelletier1, Y Liu4,5, S Laforest1,2,3, S Noël6, G Le Naour7, C Bouchard6, K Clément4,5, A Tchernof1,2,3. 1. Department of Endocrinology and Nephrology, CHU de Quebec-Laval University, Quebec City, Québec, Canada. 2. School of Nutrition, Laval University, Quebec City, Québec, Canada. 3. Quebec Heart and Lung Institute, Quebec City, Québec, Canada. 4. Nutrition Department, Institute of Cardiometabolism and Nutrition, Assistance Publique-Hôpitaux de Paris, Pitié-Salpétrière Hospital, Paris, France. 5. Sorbonne Universités, UPMC Université Paris 06, Paris, France. 6. Gynecology Unit, Laval University Medical Center, Ville de Québec, Québec, Canada. 7. Department of Pathology, Assistance Publique-Hôpitaux de Paris (AP-HP), Pitié-Salpêtrière Hospital, UIMAP, UPMC Université Paris 06, Paris, France.
Abstract
BACKGROUND: Adipose tissue fibrosis is a relatively new notion and its relationship with visceral obesity and cardiometabolic alterations remains unclear, particularly in moderate obesity. OBJECTIVE: Our objective was to examine if total and pericellular collagen accumulation are relevant for the pathophysiology of visceral obesity and related cardiometabolic risk. SUBJECTS AND METHODS: Surgical omental (OM) and subcutaneous (SC) fat samples were obtained in 56 women (age: 47.2±5.8 years; body mass index (BMI): 27.1±4.4 kg/m2). Body composition and fat distribution were measured by dual-energy X-ray absorptiometry and computed tomography, respectively. Total and pericellular collagen were measured using picrosirius red staining. CD68+ cells (total macrophages) and CD163+ cells (M2-macrophages) were identified using immunohistochemistry. RESULTS: We found that only pericellular collagen percentage, especially in OM fat, was associated with higher BMI, body fat mass and adipose tissue areas as well as lower radiologic attenuation of visceral adipose tissue and altered cardiometabolic risk variables. Strong correlations between peri-adipocyte collagen percentage and total or M2-macrophage percentages were observed in both depots. Total collagen percentage in either compartment was not related to adiposity, fat distribution or cardiometabolic risk. CONCLUSIONS: As opposed to whole tissue-based assessments of adipose tissue fibrosis, collagen deposition around the adipocyte, especially in the OM fat compartment is related to total and regional adiposity as well as altered cardiometabolic risk profile.
BACKGROUND: Adipose tissue fibrosis is a relatively new notion and its relationship with visceral obesity and cardiometabolic alterations remains unclear, particularly in moderate obesity. OBJECTIVE: Our objective was to examine if total and pericellular collagen accumulation are relevant for the pathophysiology of visceral obesity and related cardiometabolic risk. SUBJECTS AND METHODS: Surgical omental (OM) and subcutaneous (SC) fat samples were obtained in 56 women (age: 47.2±5.8 years; body mass index (BMI): 27.1±4.4 kg/m2). Body composition and fat distribution were measured by dual-energy X-ray absorptiometry and computed tomography, respectively. Total and pericellular collagen were measured using picrosirius red staining. CD68+ cells (total macrophages) and CD163+ cells (M2-macrophages) were identified using immunohistochemistry. RESULTS: We found that only pericellular collagen percentage, especially in OM fat, was associated with higher BMI, body fat mass and adipose tissue areas as well as lower radiologic attenuation of visceral adipose tissue and altered cardiometabolic risk variables. Strong correlations between peri-adipocyte collagen percentage and total or M2-macrophage percentages were observed in both depots. Total collagen percentage in either compartment was not related to adiposity, fat distribution or cardiometabolic risk. CONCLUSIONS: As opposed to whole tissue-based assessments of adipose tissue fibrosis, collagen deposition around the adipocyte, especially in the OM fat compartment is related to total and regional adiposity as well as altered cardiometabolic risk profile.
Authors: Saverio Cinti; Grant Mitchell; Giorgio Barbatelli; Incoronata Murano; Enzo Ceresi; Emanuela Faloia; Shupei Wang; Melanie Fortier; Andrew S Greenberg; Martin S Obin Journal: J Lipid Res Date: 2005-09-08 Impact factor: 5.922
Authors: Nadia Alkhouli; Jessica Mansfield; Ellen Green; James Bell; Beatrice Knight; Neil Liversedge; Ji Chung Tham; Richard Welbourn; Angela C Shore; Katarina Kos; C Peter Winlove Journal: Am J Physiol Endocrinol Metab Date: 2013-10-08 Impact factor: 4.310
Authors: Laura J McCulloch; Tom J Rawling; Kajsa Sjöholm; Niclas Franck; Simon N Dankel; Emily J Price; Bridget Knight; Neil H Liversedge; Gunnar Mellgren; Fredrik Nystrom; Lena M Carlsson; Katarina Kos Journal: Endocrinology Date: 2015-01 Impact factor: 4.736
Authors: Erik Arner; Pål O Westermark; Kirsty L Spalding; Tom Britton; Mikael Rydén; Jonas Frisén; Samuel Bernard; Peter Arner Journal: Diabetes Date: 2009-10-21 Impact factor: 9.461
Authors: Giada Ostinelli; Sofia Laforest; Scott G Denham; Marie-Frederique Gauthier; Virginie Drolet-Labelle; Emma Scott; Frédéric-Simon Hould; Simon Marceau; Natalie Z M Homer; Catherine Bégin; Ruth Andrew; André Tchernof Journal: J Clin Endocrinol Metab Date: 2022-07-14 Impact factor: 6.134
Authors: Matúš Soták; Meenu Rohini Rajan; Madison Clark; Christina Biörserud; Ville Wallenius; Carolina E Hagberg; Emma Börgeson Journal: Int J Mol Sci Date: 2022-01-04 Impact factor: 5.923